What is Bio-Rad Laboratories?
Bio-Rad Laboratories is a life science research and clinical diagnostics company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Life science research and clinical diagnostics
- Headquarters
- Hercules, CA
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; NYSE: BIO / BIO.B
What is Bio-Rad Laboratories?
Bio-Rad Laboratories is a life science research and clinical diagnostics company headquartered in Hercules, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Bio-Rad Laboratories is a life science research and clinical diagnostics company headquartered in Hercules, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Bio-Rad Laboratories should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Bio-Rad Laboratories offer?
Bio-Rad Laboratories's profile centers on Life science reagents, Clinical diagnostics, Digital PCR, Protein analysis.
- Life science reagents· Life science research and clinical diagnostics
- Clinical diagnostics· Life science research and clinical diagnostics
- Digital PCR· Life science research and clinical diagnostics
- Protein analysis· Life science research and clinical diagnostics
- Quality controls· Life science research and clinical diagnostics
- Lab instruments· Life science research and clinical diagnostics
How does Bio-Rad Laboratories make money?
Bio-Rad Laboratories makes money through commercial activity tied to life science research and clinical diagnostics.
Bio-Rad Laboratories monetizes through the model common to life science research and clinical diagnostics: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Bio-Rad Laboratories?
Bio-Rad Laboratories's named executives should be verified on the official leadership or investor-relations page before outreach.
- Bio-Rad Laboratories executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Bio-Rad Laboratories finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Bio-Rad Laboratories operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Bio-Rad Laboratories's leadership?
Bio-Rad Laboratories should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.bio-rad.com- Bio-Rad Laboratories investor relationsInvestor relations / corporate contactcontact via https://www.bio-rad.com
- Bio-Rad Laboratories sales or partnershipsCommercial contact routecontact via https://www.bio-rad.com
- Bio-Rad Laboratories media relationsMedia or communications contact routecontact via https://www.bio-rad.com
How is Bio-Rad Laboratories funded?
Bio-Rad Laboratories's current status is Public company; NYSE: BIO / BIO.B.
Bio-Rad Laboratories's capital profile is best understood through its current public-company status: Public company; NYSE: BIO / BIO.B. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Bio-Rad Laboratories get here?
Bio-Rad Laboratories's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingBio-Rad Laboratories is foundedThe company begins building in life science research and clinical diagnostics.
- Scale-upCommercial footprint expandsBio-Rad Laboratories broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; NYSE: BIO / BIO.BPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Bio-Rad Laboratories's competitors?
Bio-Rad Laboratories competes with larger incumbents and focused specialists in life science research and clinical diagnostics.
Bio-Rad Laboratories — frequently asked questions
